HYPERTENSION IN THE ELDERLY

Abernethy, 1986, Systolic blood pressure as an independent predictor of mortality in the Hypertension Detection and Follow-up Program, Am J Prev Med, 2, 123, 10.1016/S0749-3797(18)31337-0 Amery, 1985, Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial, Lancet, 1, 1349, 10.1016/S0140-6736(85)91783-0 Applegate, 1991, A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women, Arch Intern Med, 151, 1817, 10.1001/archinte.1991.00400090099018 Applegate, 1992, Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension, Arch Intern Med, 152, 1162, 10.1001/archinte.1992.00400180034005 Barker, 1998, Trends in hypertension prevalence, treatment, and control in a well-defined older population, Hypertension, 31, 552, 10.1161/01.HYP.31.1.552 Benetos, 1997, Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population, Hypertension, 30, 1410, 10.1161/01.HYP.30.6.1410 Black, 1996, Blood pressure control, Am J Med, 101, 50S, 10.1016/S0002-9343(96)00320-8 Black, 1998, Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial, Control Clin Trials, 19, 370, 10.1016/S0197-2456(98)00013-0 Black, 1996, A new classification scheme for hypertension based on relative and absolute risk with implications for treatment and reimbursement, Hypertension, 28, 719, 10.1161/01.HYP.28.5.719 Burt, 1995, Prevalence of hypertension in the U.S. adult population: Results from the third National Health and Nutrition Examination Survey, 1988–1991, Hypertension, 25, 305, 10.1161/01.HYP.25.3.305 Cruickshank, 1987, Benefits and potential harm of lowering high blood pressure, Lancet, 1, 581, 10.1016/S0140-6736(87)90231-5 Curb, 1996, Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension, JAMA, 276, 1886, 10.1001/jama.1996.03540230036032 Cushman, 1991, Treatment of hypertension in the elderly: III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: Results of a Department of Veterans Affairs Cooperative Study, Arch Intern Med, 151, 1954, 10.1001/archinte.1991.00400100042007 Cushman, 1993, Extrinsic factors in essential hypertension: Physical activity/fitness, 161 Cushman, 1998, The prevalence of stage 1 and stage 2+ isolated systolic hypertension in the United States (1988–1994) [abstr], Circulation, 97, 825 Cushman, 1998, The Prevention and Treatment of Hypertension Study (PATHS): Effects of an alcohol treatment program on blood pressure, Arch Intern Med, 158, 1197, 10.1001/archinte.158.11.1197 Cushman, 1999, Alcohol use and blood pressure, 263 Cutler, 1998, Calcium-channel blockers for hypertension—uncertainty continues, N Engl J Med, 338, 679, 10.1056/NEJM199803053381009 Dahlof, 1991, Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension), Lancet, 338, 1281, 10.1016/0140-6736(91)92589-T Davis, 1996, Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), Am J Hypertens, 9, 342, 10.1016/0895-7061(96)00037-4 Dyer, 1975, An analysis of the relationship of systolic blood pressure, serum cholesterol, and smoking to 14-year mortality in the Chicago Peoples Gas Company Study: II. Coronary and cardiovascular-renal mortality in two competing risk models, J Chron Dis, 28, 571, 10.1016/0021-9681(75)90070-3 Estacio, 1998, The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension, N Engl J Med, 338, 645, 10.1056/NEJM199803053381003 Fang, 1995, Isolated diastolic hypertension: A favorable finding among young and middle-aged hypertensive subjects, Hypertension, 26, 377, 10.1161/01.HYP.26.3.377 Forette, 1998, Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial, Lancet, 352, 1347, 10.1016/S0140-6736(98)03086-4 Franklin, 1997, Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study, Circulation, 96, 308, 10.1161/01.CIR.96.1.308 Goldstein, 1990, Treatment of hypertension in the elderly: II. Cognitive and behavioral function: Results of a Department of Veterans Affairs Cooperative Study, Hypertension, 15, 361, 10.1161/01.HYP.15.4.361 Hansson, 1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6 Heckbert, 1997, The association of antihypertensive agents with MRI white matter findings and with modified mini-mental state examination in older adults, J Am Geriatr Soc, 45, 1423, 10.1111/j.1532-5415.1997.tb03191.x Hypertension Detection and Follow-up Program Cooperative Group, 1979, Five-year findings of the Hypertension Detection and Follow-up Program: II. Mortality by race, sex and age, JAMA, 242, 2572, 10.1001/jama.1979.03300230028022 Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, 1997, The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI), Arch Intern Med, 157, 2413, 10.1001/archinte.1997.00440420033005 Kannel, 1980, Perspectives on systolic hypertension: The Framingham study, Circulation, 61, 1179, 10.1161/01.CIR.61.6.1179 Kostis, 1997, Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension, JAMA, 278, 212, 10.1001/jama.1997.03550030052033 Madhavan, 1994, The relationship of pulse pressure and blood pressure reduction to the incidence of myocardial infarction, Hypertension, 23, 395, 10.1161/01.HYP.23.3.395 Materson, 1990, Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study, Hypertension, 15, 348, 10.1161/01.HYP.15.4.348 Materson, 1993, Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo, N Engl J Med, 328, 914, 10.1056/NEJM199304013281303 Materson, 1995, Department of Veterans Affairs Single-Drug Therapy of Hypertension Study: Revised figures and new data, Am J Hypertens, 8, 189, 10.1016/0895-7061(94)00196-I Materson, 1995, Results of combination antihypertensive therapy after failure of each of the components, J Hum Hypertens, 9, 791 Messerli, 1998, Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review, JAMA, 279, 1903, 10.1001/jama.279.23.1903 1992, MRC Working Party Medical Research Council trial of treatment of hypertension in older adults: Principal results, BMJ, 304, 405, 10.1136/bmj.304.6824.405 National High Blood Pressure Education Program Working Group, 1994, National High Blood Pressure Education Program on Hypertension in the Elderly, Hypertension, 23, 275, 10.1161/01.HYP.23.3.275 Neaton, 1992, Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group, Arch Intern Med, 152, 56, 10.1001/archinte.1992.00400130082009 Ofili, 1998, Effect of treatment of isolated systolic hypertension on left ventricular mass, JAMA, 279, 778, 10.1001/jama.279.10.778 Pahor, 1998, Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the Systolic Hypertension in the Elderly Program (SHEP), Arch Intern Med, 158, 1340, 10.1001/archinte.158.12.1340 Preston, 1998, Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy, JAMA, 280, 1168, 10.1001/jama.280.13.1168 Sagie, 1993, The natural history of borderline isolated systolic hypertension, N Engl J Med, 329, 1912, 10.1056/NEJM199312233292602 Savage, 1998, Influence of long-term, low-dose diuretic-based antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension, Arch Intern Med, 158, 741, 10.1001/archinte.158.7.741 SHEP Cooperative Research Group, 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP), JAMA, 265, 3255, 10.1001/jama.1991.03460240051027 SHEP Cooperative Research Group, 1993, Implications of the Systolic Hypertension in the Elderly Program, Hypertension, 21, 335, 10.1161/01.HYP.21.3.335 Staessen, 1997, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators: Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, Lancet, 350, 764, 10.1016/S0140-6736(97)05381-6 Stamler, 1993, Blood pressure, systolic and diastolic, and cardiovascular risk, Arch Intern Med, 153, 598, 10.1001/archinte.1993.00410050036006 Tatti, 1998, Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM, Diabetes Care, 21, 597, 10.2337/diacare.21.4.597 The Management Committee, Australian National Blood Pressure Study, 1981, Treatment of mild hypertension in the elderly, Med J Aust, 2, 398, 10.5694/j.1326-5377.1981.tb101027.x United Kingdom Prospective Diabetes Group, 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes, BMJ, 317, 703, 10.1136/bmj.317.7160.703 United Kingdom Prospective Diabetes Group, 1998, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes, BMJ, 317, 713, 10.1136/bmj.317.7160.713 VA Cooperative Study Group on Antihypertensive Agents, 1972, Effects of treatment on morbidity in hypertension: III. Influence of age, diastolic pressure, and prior cardiovascular disease: Further analysis of side effects, Circulation, 45, 991, 10.1161/01.CIR.45.5.991 Whelton, 1998, A randomized controlled trial of nonpharmacologic interventions in the elderly (TONE), JAMA, 279, 839, 10.1001/jama.279.11.839